| ACE Inhibitors may Reduce Risk of Cardiovascular Disease and Death -
12-04-2006, 07:15 PM
Patients with coronary artery disease may benefit from angiotension converting enzyme (ACE) inhibitors, drugs commonly used to treat high blood pressure. A new study reveals the medication may reduce the risk of cardiovascular disease and death in coronary artery disease patients.
Researchers in Paris analyzed seven previous studies of ACE inhibitors in patients with coronary artery disease. Almost 34,000 patients took part in the trials. They were followed for a minimum of two years and an average of 4.4 years.
The new report shows ACE inhibitors significantly reduce the risk of heart attacks, strokes and death in patients with coronary artery disease. The drugs also seemed to reduce the risk of developing diabetes, hospitalization for congestive heart failure and cardiac arrest.
"In this overview of randomized trials of ACE inhibitors for the long-term secondary prevention of coronary artery disease in patients without left ventricular dysfunction or heart failure, active treatment was associated with a highly significant reduction in all-cause mortality and all major cardiovascular events," study authors say.
Angel xenoMED | NDR “Nothing brings me more happiness than helping people in the society. It is a goal and an essential part of my life - a kind of destiny.” | 
Linear Mode
